William Pedranti

William Pedranti

Fondatore presso IACTA Pharmaceuticals, Inc.

Health Technology
Consumer Services
Commercial Services

Profilo

William Pedranti is the founder of two companies.
He founded SCILEX Pharmaceuticals, Inc. in 2011 and was the Chief Operating Officer.
He also founded IACTA Pharmaceuticals, Inc. in 2016 and is the Chief Administrative Officer.
Currently, he is the Chief Executive Officer & Director at Visgenx, Inc. since 2023 and the Chief Executive Officer at Ellsworth Construction LLC.
He previously worked as Vice President & General Counsel at Spectrum Pharmaceuticals, Inc. and as a Corporate Associate at Latham & Watkins LLP.
Mr. Pedranti received his undergraduate degree from the University of Southern California and his graduate degree from Georgetown University.

Posizioni attive di William Pedranti

SocietàPosizioneInizio
Fondatore 01/01/2016
Amministratore Delegato -
Amministratore Delegato 05/06/2023
Tutte le posizioni attive di William Pedranti

Precedenti posizioni note di William Pedranti

SocietàPosizioneFine
Fondatore 01/04/2019
Corporate Officer/Principal -
SPECTRUM PHARMACEUTICALS, INC. Consigliere Generale -
Vedi nel dettaglio l'esperienza di William Pedranti

Formazione di William Pedranti

Georgetown University Graduate Degree
University of Southern California Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di William Pedranti

Relazioni

28

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
SPECTRUM PHARMACEUTICALS, INC.

Health Technology

Aziende private5

Commercial Services

Health Technology

Health Technology

Industrial Services

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. William Pedranti
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA